FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ingunn Stefansson

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Physiology

Devices

Protein Array Analysis

Co-author Network

Publications

TOP 3
K Krüger; Ingunn M Stefansson; Turid Aas; Jarle Arnes; Karin Collett; Lars A Akslen
Microvessel proliferation by co-expression of endothelial nestin and Ki-67 is associated with a basal-like phenotype and aggressive features in breast cancer.
Elisabeth Wik; Ronald Simon; Ingunn M Stefansson; Jone Trovik; Henrica M J Werner; Lars A Akslen; Even Birkeland; Erling A Hoivik; Frederik Holst; Karl-Henning Kalland; Camilla Krakstad; Kanthida Kusonmano; Karen Mauland; Siv Mjos; Anne Margrete Oyan; Kjell Petersen; William Ricketts; Helga B Salvesen
High Phospho-Stathmin(Serine38) Expression Identifies Aggressive Endometrial Cancer and Suggests an Association with PI3K Inhibition.
Elisabeth Wik; Ingunn M Stefansson; Jone Trovik; Henrica M J Werner; Lars A Akslen; Even Birkeland; Erling A Hoivik; Karl-Henning Kalland; Camilla Krakstad; Monica Mannelqvist; Siv Mjos; Anne Margrete Oyan; Maria Baroy Raeder; Helga B Salvesen
Lack of estrogen receptor-α is associated with epithelial-mesenchymal transition and PI3K alterations in endometrial carcinoma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ingunn Stefansson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: K Krüger; Ingunn M Stefansson; Turid Aas; Jarle Arnes; Karin Collett; Lars A Akslen
Microvessel proliferation by co-expression of endothelial nestin and Ki-67 is associated with a basal-like phenotype and aggressive features in breast cancer.
Breast (Edinburgh, Scotland) 2013;22(3):282-8.
2013: Elisabeth Wik; Ronald Simon; Ingunn M Stefansson; Jone Trovik; Henrica M J Werner; Lars A Akslen; Even Birkeland; Erling A Hoivik; Frederik Holst; Karl-Henning Kalland; Camilla Krakstad; Kanthida Kusonmano; Karen Mauland; Siv Mjos; Anne Margrete Oyan; Kjell Petersen; William Ricketts; Helga B Salvesen
High Phospho-Stathmin(Serine38) Expression Identifies Aggressive Endometrial Cancer and Suggests an Association with PI3K Inhibition.
Clinical cancer research : an official journal of the American Association for Cancer Research 2013;19(9):2331-41.
2013: Elisabeth Wik; Ingunn M Stefansson; Jone Trovik; Henrica M J Werner; Lars A Akslen; Even Birkeland; Erling A Hoivik; Karl-Henning Kalland; Camilla Krakstad; Monica Mannelqvist; Siv Mjos; Anne Margrete Oyan; Maria Baroy Raeder; Helga B Salvesen
Lack of estrogen receptor-α is associated with epithelial-mesenchymal transition and PI3K alterations in endometrial carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2013;19(5):1094-105.
2013: Maria Baroy Raeder; Lars A Akslen; Rameen Beroukhim; Even Birkeland; Frederik Holst; Karl-Henning Kalland; Camilla Krakstad; Antje Krohn; Jill P Mesirov; Susan E Moody; Anne Margrete Oyan; Steven Schumacher; Shyemaa Shehata; Ronald Simon; Ingunn M Stefansson; Pablo Tamayo; Jone Trovik; Henrica Mj Werner; Elisabeth Wik; Travis I Zack; Helga B Salvesen
Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers.
PloS one 2013;8(2):e54873.
2012: Jarle Arnes; Jan P Baak; William D Foulkes; Per E Lønning; Ingunn M Stefansson; Oddbjørn Straume; Lars A Akslen
Vascular proliferation is a prognostic factor in breast cancer.
Breast cancer research and treatment 2012;133(2):501-10.
2012: Camilla Krakstad; Maria Baroy Raeder; Lars A Akslen; E Birkeland; I B Engelsen; K H Kalland; Ingunn M Stefansson; J Trovik; H M J Werner; E Wik; Anne Margrete Oyan; Helga B Salvesen
Loss of GPER identifies new targets for therapy among a subgroup of ERα-positive endometrial cancer patients with poor outcome.
British journal of cancer 2012;106(10):1682-8.
2012: Monica Mannelqvist; Marsha A Moses; Maria Baroy Raeder; Helga B Salvesen; Ingunn M Stefansson; Elisabeth Wik; Anne Margrete Oyan; Karl-Henning Kalland; Kanthida Kusonmano; Lars A Akslen
Lipocalin 2 expression is associated with aggressive features of endometrial cancer.
BMC cancer 2012;12():169.
2011: Hawa Nalwoga; Ingunn M Stefansson; Henry Wabinga; Jarle Arnes; William D Foulkes; Lars A Akslen
Vascular proliferation is increased in basal-like breast cancer.
Breast cancer research and treatment 2011;130(3):1063-71.
2011: Jone Trovik; Ingrid Vandenput; Elisabeth Wik; Anne C Staff; Ingunn M Stefansson; Solveig Tingulstad; Lars A Akslen; Frederic Amant; Janusz Marcickiewicz; Tormund S Njolstad; Helga B Salvesen
Stathmin overexpression identifies high-risk patients and lymph node metastasis in endometrial cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(10):3368-77.
2011: Ingrid Vandenput; Ignace Vergote; Elisabeth Wik; Lars Akslen; Karin Leunen; Philippe Moerman; Helga Salvesen; Ingunn M Stefansson; Jone Trovik; Frederic Amant
Evolution in endometrial cancer: evidence from an immunohistochemical study.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2011;21(2):316-22.
2011: Monica Mannelqvist; Ingunn M Stefansson; Geir Bredholt; Trond Hellem Bø; Anne Margrete Oyan; Inge Jonassen; Karl-Henning Kalland; Helga B Salvesen; Lars A Akslen
Gene expression patterns related to vascular invasion and aggressive features in endometrial cancer.
The American journal of pathology 2011;178(2):861-71.
2009: Elisabeth Wik; Jone Trovik; Ole-Erik Iversen; Ingeborg B Engelsen; Ingunn M Stefansson; Liv C Vestrheim; HK Haugland; Lars A Akslen; Helga B Salvesen
Deoxyribonucleic acid ploidy in endometrial carcinoma: a reproducible and valid prognostic marker in a routine diagnostic setting.
American journal of obstetrics and gynecology 2009;201(6):603.e1-7.
2009: Hannah Ni Bhriain; Jone Trovik; Elisabeth Wik; Ingunn M Stefansson; Lars A Akslen; Helga B Salvesen; Anne Cathrine Staff
Plasma calprotectin concentrations in women with endometrial carcinoma.
Gynecologic oncology 2009;114(3):491-5.
2009: Helga B Salvesen; S L Carter; M Mannelqvist; Amit Dutt; Gad Getz; Ingunn M Stefansson; Maria Baroy Raeder; M L Sos; I B Engelsen; J Trovik; E Wik; H Greulich; Trond Hellem Bø; Inge Jonassen; R K Thomas; T Zander; L A Garraway; Anne Margrete Oyan; William R Sellers; Karl-Henning Kalland; Matthew Meyerson; Lars A Akslen; Rameen Beroukhim
Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(12):4834-9.
2009: Jarle Arnes; Louis R Bégin; Ingunn M Stefansson; Jean-Sebastien Brunet; T O Nielsen; William D Foulkes; Lars A Akslen
Expression of epidermal growth factor receptor in relation to BRCA1 status, basal-like markers and prognosis in breast cancer.
Journal of clinical pathology 2009;62(2):139-46.
2009: Monica Mannelqvist; Ingunn M Stefansson; Helga B Salvesen; Lars A Akslen
Importance of tumour cell invasion in blood and lymphatic vasculature among patients with endometrial carcinoma.
Histopathology 2009;54(2):174-83.
2008: Ingeborg B Engelsen; Ingunn M Stefansson; Lars A Akslen; Helga B Salvesen
GATA3 expression in estrogen receptor alpha-negative endometrial carcinomas identifies aggressive tumors with high proliferation and poor patient survival.
American journal of obstetrics and gynecology 2008;199(5):543.e1-7.
2008: Amit Dutt; Helga B Salvesen; Tzu-Hsiu Chen; Alex H Ramos; Robert C Onofrio; Charlie Hatton; Richard Nicoletti; Wendy Winckler; Rupinder Grewal; Megan Hanna; Nicolas Wyhs; Liuda Ziaugra; Daniel J Richter; Jone Trovik; Ingeborg B Engelsen; Ingunn M Stefansson; Tim Fennell; Kristian Cibulskis; Michael C Zody; Lars A Akslen; Stacey Gabriel; Kwok-Kin Wong; William R Sellers; Matthew Meyerson; Heidi Greulich
Drug-sensitive FGFR2 mutations in endometrial carcinoma.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(25):8713-7.
2008: I B Engelsen; M Mannelqvist; Ingunn M Stefansson; S L Carter; Rameen Beroukhim; Anne Margrete Øyan; A P Otte; K H Kalland; Lars A Akslen; Helga B Salvesen
Low BMI-1 expression is associated with an activated BMI-1-driven signature, vascular invasion, and hormone receptor loss in endometrial carcinoma.
British journal of cancer 2008;98(10):1662-9.
2008: Ingeborg B Engelsen; Ingunn M Stefansson; Rameen Beroukhim; William R Sellers; Matthew Meyerson; Lars A Akslen; Helga B Salvesen
HER-2/neu expression is associated with high tumor cell proliferation and aggressive phenotype in a population based patient series of endometrial carcinomas.
International journal of oncology 2008;32(2):307-16.
2006: Ingeborg B Engelsen; Ingunn M Stefansson; Lars A Akslen; Helga B Salvesen
Pathologic expression of p53 or p16 in preoperative curettage specimens identifies high-risk endometrial carcinomas.
American journal of obstetrics and gynecology 2006;195(4):979-86.
2006: Ingunn M Stefansson; Helga B Salvesen; Lars A Akslen
Vascular proliferation is important for clinical progress of endometrial cancer.
Cancer research 2006;66(6):3303-9.
2006: Ingunn M Stefansson; Helga B Salvesen; Lars A Akslen
Loss of p63 and cytokeratin 5/6 expression is associated with more aggressive tumors in endometrial carcinoma patients.
International journal of cancer. Journal international du cancer 2006;118(5):1227-33.
2006: Karin Collett; Geir Egil Eide; Jarle Arnes; Ingunn M Stefansson; Johan Eide; Audun Braaten; Turid Aas; Arie P Otte; Lars A Akslen
Expression of enhancer of zeste homologue 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(4):1168-74.
2006: Ingeborg M Bachmann; Ole Johan Halvorsen; Karin Collett; Ingunn M Stefansson; Oddbjørn Straume; Svein A Haukaas; Helga B Salvesen; Arie P Otte; Lars A Akslen
EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(2):268-73.
2005: Helga B Salvesen; Rajiv Kumar; Ingunn M Stefansson; Sabrina Angelini; Nicola MacDonald; Johanna Smeds; Ian J Jacobs; Kari Hemminki; Soma Das; Lars A Akslen
Low frequency of BRAF and CDKN2A mutations in endometrial cancer.
International journal of cancer. Journal international du cancer 2005;115(6):930-4.
2005: Jarle Arnes; Jean-Sebastien Brunet; Ingunn M Stefansson; Louis R Bégin; Nora Wong; Pierre O Chappuis; Lars A Akslen; William D Foulkes
Placental cadherin and the basal epithelial phenotype of BRCA1-related breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(11):4003-11.
2005: Karin Collett; Ingunn M Stefansson; Johan Eide; Audun Braaten; Hege Wang; Geir Egil Eide; Steinar Thoresen; William D Foulkes; Lars A Akslen
A basal epithelial phenotype is more frequent in interval breast cancers compared with screen detected tumors.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(5):1108-12.
2004: Helga B Salvesen; Ingunn M Stefansson; Ellen I Kretzschmar; Paula Gruber; Nicola D Macdonald; Andy Ryan; Ian J Jacobs; Lars A Akslen; Soma Das
Significance of PTEN alterations in endometrial carcinoma: a population-based study of mutations, promoter methylation and PTEN protein expression.
International journal of oncology 2004;25(6):1615-23.
2004: Nicola D Macdonald; Helga B Salvesen; Andy Ryan; S Malatos; Ingunn M Stefansson; Ole-Erik Iversen; Lars A Akslen; Soma Das; Ian J Jacobs
Molecular differences between RER+ and RER- sporadic endometrial carcinomas in a large population-based series.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2004;14(5):957-65.
2004: Ingunn M Stefansson; Helga B Salvesen; heike immervoll; Lars A Akslen
Prognostic impact of histological grade and vascular invasion compared with tumour cell proliferation in endometrial carcinoma of endometrioid type.
Histopathology 2004;44(5):472-9.
2004: Ingunn M Stefansson; Helga B Salvesen; Lars A Akslen
Prognostic impact of alterations in P-cadherin expression and related cell adhesion markers in endometrial cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(7):1242-52.
2004: William D Foulkes; Jean-Sebastien Brunet; Ingunn M Stefansson; Oddbjørn Straume; Pierre O Chappuis; Louis R Bégin; Nancy Hamel; John R Goffin; Nora Wong; Michel Trudel; Linda Kapusta; Peggy Porter; Lars A Akslen
The prognostic implication of the basal-like (cyclin E high/p27 low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer.
Cancer research 2004;64(3):830-5.
2003: Helga B Salvesen; Mine G Gulluoglu; Ingunn M Stefansson; Lars A Akslen
Significance of CD 105 expression for tumour angiogenesis and prognosis in endometrial carcinomas.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2003;111(11):1011-8.
2003: William D Foulkes; Ingunn M Stefansson; Pierre O Chappuis; Louis R Bégin; John R Goffin; Nora Wong; Michel Trudel; Lars A Akslen
Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer.
Journal of the National Cancer Institute 2003;95(19):1482-5.
2002: Helga B Salvesen; Ingunn M Stefansson; May Britt Kalvenes; Soma Das; Lars A Akslen
Loss of PTEN expression is associated with metastatic disease in patients with endometrial carcinoma.
Cancer 2002;94(8):2185-91.
2002: Ingunn M Stefansson; Lars A Akslen; Nicola MacDonald; Andy Ryan; Soma Das; Ian J Jacobs; Helga B Salvesen
Loss of hMSH2 and hMSH6 expression is frequent in sporadic endometrial carcinomas with microsatellite instability: a population-based study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(1):138-43.